Key stats
About MIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA MEDTECH ETF
Home page
Inception date
Aug 3, 2023
Replication method
Synthetic
Dividend treatment
Distributes
Primary advisor
Mirae Asset Global Investments (Hong Kong) Ltd.
ISIN
HK0000945649
The investment objective of the Sub-Fund is to provide investment results that, before fees and expenses, closely correspond to the performance of the Solactive China MedTech Index (the Index).
Classification
Returns
1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
---|---|---|---|---|---|---|
Price performance | — | — | — | — | — | — |
NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Health Services
Retail Trade
Stocks99.83%
Health Technology59.61%
Health Services11.07%
Retail Trade10.78%
Technology Services9.81%
Process Industries8.55%
Bonds, Cash & Other0.17%
Cash0.17%
Stock breakdown by region
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history